NOVO HOLDINGS A/S

CIK 1388325 · View on SEC EDGAR ↗

Portfolio value
$1.7B
#1,681 of 9,443 by 13F value · top 17.8%
Positions
25
As of
June 30, 2026

Portfolio value QoQ: +39.5% 13F does not disclose cash

Top 10 holdings weight
73.48%
Top 25 holdings weight
100.00%
Positions above 1%
22
Effective number of positions
14.4

Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)

Turnover Q2 2026: 11.55% Est. buys $396,823,450 · sells $170,802,679

Median holding: 4.0 quarters Tracked Q4 2024–Q2 2026 · 54.3% still held

New positions
6
Increased
2
Decreased
8
Closed
3
On this page

Performance vs S&P 500

Tracked Q4 2025–Q2 2026
+25.4%
S&P 500 total return (same window)
+8.7%
Excess return
+16.7%

Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.

Priceable coverage: 100.0% · Options excluded: 0.0%

Sector breakdown

Healthcare
55.8%
Technology
14.5%
Financial Services
9.1%
Retail
4.2%
Industrials
0.1%
Other/Unmapped
16.3%

Full portfolio 25 positions

Type Streak 8Q trend
EWTX Edgewise Therapeutics, Inc. - Common Stock $217,370,500 12.62% 5,350,000 $48,845,500
ASML ASML Holding N.V. - New York Registry Shares $188,889,370 10.97% 94,946 $63,481,845
Unknown issuer (CUSIP: 423494103) $153,551,602 8.92% 4,180,550 Up ×1
BN Brookfield Corporation Class A Limited Voting Shares $149,534,399 8.68% 3,496,245 $8,041,364
MPLT MapLight Therapeutics, Inc. - Common Stock $132,128,532 7.67% 3,686,622 $57,179,507
MIRM Mirum Pharmaceuticals, Inc. - common stock $131,703,750 7.65% 1,125,000 $9,300,250 Down ×1
Unknown issuer (CUSIP: 05348Y105) $127,837,874 7.42% 3,883,289 Up ×1
CRM Salesforce, Inc. Common Stock $61,596,675 3.58% 393,187 $-11,799,542
AVBP ArriVent BioPharma, Inc. - Common Stock $52,110,000 3.03% 1,500,000 $7,304,784 Down ×1
ELVN Enliven Therapeutics, Inc. - Common Stock $50,750,000 2.95% 1,000,000 $574,000 Down ×2
CRNX Crinetics Pharmaceuticals, Inc. - Common Stock $49,394,400 2.87% 1,320,000 $-6,901,600 Down ×2
PHVS Pharvaris N.V. - Ordinary Shares $48,412,000 2.81% 1,400,000 $-1,025,500 Down ×1
FND Floor & Decor Holdings, Inc. Common Stock $47,309,920 2.75% 797,000 Up ×1
PCVX Vaxcyte, Inc. - Common Stock $46,504,000 2.70% 800,000 $-3,470,600 Down ×2
FDMT 4D Molecular Therapeutics, Inc. - Common Stock $43,214,067 2.51% 3,249,178 $9,225,706 Down ×1
VRDN Viridian Therapeutics, Inc. - Common Stock $39,219,950 2.28% 2,135,000 $99,950 Up ×1
CLDX Celldex Therapeutics, Inc. - Common Stock $38,140,250 2.21% 1,025,000 $76,250 Down ×1
ALMS Alumis Inc. - Common Stock $30,954,000 1.80% 1,100,000 Up ×1
XENE Xenon Pharmaceuticals Inc. - Common Shares $29,301,038 1.70% 485,438 $1,072,818
BABA Alibaba Group Holding Limited American Depositary Shares each representing eight Ordinary share $24,698,245 1.43% 257,327 $-7,586,000
DYN Dyne Therapeutics, Inc. - Common Stock $21,330,351 1.24% 960,394 Up ×1
BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock $17,145,000 1.00% 2,250,000 $-2,419,011 Up ×2
INSM Insmed Incorporated - Common Stock $12,871,486 0.75% 120,723
MQ Marqeta, Inc. - Class A Common Stock $7,170,902 0.42% 441,558 $5,369,345
LNZA LanzaTech Global, Inc. - Common Stock $1,078,569 0.06% 158,148 $-1,453,380

Biggest new bets

New positions opened this quarter, largest first.

Security Value Shares % of portfolio
Unknown issuer (CUSIP: 423494103) $153,551,602 4,180,550 8.92%
Unknown issuer (CUSIP: 05348Y105) $127,837,874 3,883,289 7.42%
FND $47,309,920 797,000 2.75%
ALMS $30,954,000 1,100,000 1.80%
DYN $21,330,351 960,394 1.24%
INSM $12,871,486 120,723 0.75%

Top movers (QoQ)

Security Action Shares Δ Value Δ
ASML Price move only +0 +$63.5M
MPLT Price move only +0 +$57.2M
EWTX Price move only +0 +$48.8M
CRM Price move only +0 -$11.8M
MIRM Trimmed -200K +$9.3M
FDMT Trimmed -402K +$9.2M
BN Price move only +0 +$8.0M
BABA Price move only +0 -$7.6M
AVBP Trimmed -442K +$7.3M
CRNX Trimmed -230K -$6.9M

Exited positions

Includes corporate events (mergers, delistings) — not all exits are sells

Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.

SecurityQuarter Shares before Value before Price since exit
VTI Dec. 31, 2025 1,038,550 $340,820,954 No longer tracked
TEM March 31, 2025 4,074,419 $137,552,385 37.6%
MRUS Dec. 31, 2025 750,000 $70,612,500 No longer tracked
ZBIO March 31, 2026 1,450,000 $52,649,500 63.2%
RXRX Dec. 31, 2025 7,929,835 $38,697,595 -17.0%
APGE June 30, 2026 450,000 $37,876,500 1.6%
BMRN June 30, 2026 660,000 $37,283,400 18.2%
INSM March 31, 2026 200,000 $34,808,000 -23.3%
BPMC Sept. 30, 2025 264,956 $33,962,060 No longer tracked
CRGX March 31, 2025 1,663,724 $23,990,900 No longer tracked
FOLD June 30, 2025 2,750,000 $22,440,000 No longer tracked
CBLL Sept. 30, 2025 900,000 $16,857,000 108.4%
VERV June 30, 2025 3,000,000 $13,710,000 No longer tracked
RCKT June 30, 2025 1,100,000 $7,337,000 44.1%
VALN June 30, 2026 1,057,421 $6,608,881 31.5%
MRSN March 31, 2025 4,250,000 $6,077,500 No longer tracked
LXEO June 30, 2025 1,122,581 $3,895,356 28.0%
KYTX June 30, 2025 1,850,000 $3,570,500 170.2%
ABCL Sept. 30, 2025 652,529 $2,238,174 126.6%
IOBT March 31, 2026 2,512,453 $1,529,833 No longer tracked
GLTO Dec. 31, 2025 86,579 $322,074 No longer tracked